Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.
第一作者:
G,Frasci
第一单位:
Department of Senology. Electronic address: giuseppe.frasci@libero.it.
作者:
医学主题词
成年人(Adult);老年人(Aged);算法(Algorithms);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);癌(Carcinoma);顺铂(Cisplatin);综合疗法(Combined Modality Therapy);疾病恶化(Disease Progression);用药计划表(Drug Administration Schedule);表柔比星(Epirubicin);依托泊甙(Etoposide);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);意大利(Italy);中年人(Middle Aged);紫杉酚(Paclitaxel);手术前护理(Preoperative Care);紫杉烷类(Taxoids)
DOI
10.1093/annonc/mdp356
PMID
19815652
发布时间
2020-06-26
- 浏览16
Annals of oncology
707-716页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



